Virtual exercise coach tested for heart failure – but trial stops early
NCT ID NCT05985395
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a program called HEART Camp Connect, which uses a virtual coach to help adults with heart failure exercise 150 minutes per week. Only 11 people enrolled before the trial was stopped. Researchers wanted to see if the program improved exercise habits and heart-related quality of life over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual exercise coaching program (HEART Camp Connect)
- What this could lead to
- If successful, this approach could help people with heart failure stick to an exercise routine and feel better day-to-day.
- What could go wrong
- The trial was terminated early with only 11 participants, so results are very limited. It is unclear if the program works better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
11 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Nov 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of heart failure (HF) with an ejection fraction (EF) ≥50% * Age ≥18 years * English-speaking * Echocardiogram in prior 12 months * Stable pharmacologic therapy in past 30 days Exclusion Criteria: * Score\<6 on a diagnostic algorithm * Life-limiting illness precluding study completion * Clinical evidence of decompensated HF * Unstable angina or marked shortness of breath on exertion at \<2 metabolic equivalents * Myocardial infarction, coronary artery bypass surgery, or biventricular pacemaker \<6 weeks * Orthopedic or neuromuscular disorders preventing participation in aerobic exercise * Cardiopulmonary exercise test results that preclude safe exercise * Unwilling/unable to complete pre-randomization procedures * Pregnancy * Implantable cardioverter-defibrillator
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure with preserved ejection fraction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198-5330, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Implanted device aims to ease heart failure symptoms
- Can a once-daily pill ease the burden of a common heart failure?
- A glowing dye could expose hidden heart scarring
- Can GLP-1 drugs improve heart function during exercise in Obesity-Related heart failure?
- Could tiny heart vessels hold the key to a common form of heart failure?
- Can a diabetes drug keep the heart in rhythm?